CS
BHVN icon

Candriam SCA’s Biohaven BHVN Stock Holding History

Candriam SCA’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-128,845
Closed -$1.93M – 693
2025
Q3 		$1.93M Sell
128,845
-398
-0.3% -$5.79K 0.01% 508
2025
Q2 		$1.82M Buy
129,243
+34,664
+37% +$618K 0.01% 508
2025
Q1 		$2.27M Sell
94,579
-600
-0.6% -$21.2K 0.01% 472
2024
Q4 		$3.55M Sell
95,179
-4,821
-5% -$225K 0.02% 406
2024
Q3 		$5M Hold
100,000
– – 0.03% 364
2024
Q2 		$3.47M Hold
100,000
– – 0.02% 395
2024
Q1 		$5.47M Buy
+100,000
New +$4.95M 0.04% 327

Other funds holding BHVN

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Candriam SCA's BHVN Position: Q4 2025 in Review

Candriam SCA sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 128,845 shares — an estimated $1.93M sold.

Candriam SCA first reported a position in BHVN in Q1 2024 and held it in 7 quarters. The position peaked at $5.47M in Q1 2024. 273 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • Candriam SCA reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
  • Candriam SCA sold 128,845 Biohaven shares in Q4 2025, an estimated $1.93M.
  • Candriam SCA first reported a position in Biohaven in Q1 2024 and held it in 7 quarters.
  • Candriam SCA's Biohaven position peaked at $5.47M in Q1 2024.
  • 273 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.